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B , ~ *  Wh~k~ brachtal adery (BA) endothell,~l dy~unclton cowelates 
with athefo~¢lefo~¢ nsk factors m men. the_ influence of risk factors and 
~mopau~ h~lory on BA h.~-~ion in ~ is not clear We hypolhesOzeq 
;hal mef lo~a~l  s~lus and atheroseterotiC nsk fa~om am determinants of 
OA e~o~ hm~!  in women. 
~ ' ~  Women w~th che~t pare ~n = tO6; mean ~ge 58 years! m the 
NHLBI Women's Ischem~¢ Syndrome Evaluation (WI~E) hacl BA diameter 
measured t~,ete~e anO after mchem~a-~ hypefemla to assess fl~;~ mecl~, 
areal ~,i~lata|ton (FMD). a~ marlKl~ of endothelia! fUP4:tlon, We a~ssed  relation 
of FMD to menopausal status, nsk factors for coronan/arten/d~sease (CAD), 
and p~eser~s ot CAD, 
Res~"  FMD was negatively co~related w~th age (Spearman co~relat~on 
-028. p ~ 0.0t) and systel~c BP ( -0~,  P = 0.02) A~ence of FMD was 
associated with ~ u s e  Ip = 002), d~ab~tes (p ~ 001), prior PTCA IP 
= 0.0,?.), an~ presence el 3 Of mo~e CAD nsk faclocs (p = 0.02) Assooat~on 
el FMD with ~o#e, -~~l  CAD ( ~ 50% stencmm) was not s~g~cant 
IP = 0.08) M;.~tvanate regression anaiys~s found age and diabetes were 
~ndependent s;gndt~aLm ~ofs  of FMD 
C~n:  Menopause and ~abetes h~ston/influence BA F MD m women 
with chest pa~n In particular, eider women w~lh chest pa~n and multiple CAD 
nsk factors are p'ed~sposed to brach~at aRen/en(l~l~l~al dysfunction 
~ Endothe l ia l  DystunctL)n o f  Coronary  Ar tery  in 
Sub~ W'dh Impaired G lucose  To lerance 
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Fuku~, J~z="t 
Backgrounds and Mett~:xts: To deterrn, ne whether i~ i red  gtucose toler- 
ance affects vasomo~n of coronary a~n/, we e~aluatecl maximal increases 
of the coronary brood flow ~r'~;.~"e~ ~ mtracorenary ,nfus~on of adenoszn~ 
t~phosph~c a,,"~d o~ acetylc~,0tme (Fr4 or FIE. respectrve~), using ~Jantitao 
twe cot'onary aReno~aphy and ~raco~onan/~0~op~er-t~:~'d g ewre ,n 169 
sut~ects, whose g~ucoee tolerance w~s graded by oral 75 g-glucose toler- 
ance test We also evaluated the C~ni~ut~nS ot other coronary nsk factors 
and d~aat~c vanabtes u~on the vasomohon m SU~leCt5 with impaired glucose 
tolerance (IGT). 
TaSte I 
DM tGT N 
In = 3~) tn = 971 in = 34) 
FN 153 : 85% 181 : ,'7% 189 ~ 79% 
Tattle 2 
nRF smoking 51Rl 
Szandar~ ¢oeff~c~em IF ~,'~) - 0 29 t8 2) 0 24 (5 4) O 19 (4 3) 
ResultS: FN tn tGT was not d=fferent from that tn sublects with diabetes 
mellitus (DM) or in subjects with normal gluceso tolerance test (N), FE in IGT 
was lower then that in N (IGT vs N: p = 0.04, Table 1) By multiple stepw~se 
regression analyses tn IGT, number el coro,"tan/nsk factors (nRF) proposed 
by Framingham Hear Study. smoking, and summation of insulin levels (slRI) 
on glucose tolerance test were determinants for FE (multiple coeffioent 048, 
Table 2) In followed-up subjects achieving two or more reduCtion ot the nRF, 
or cessation of smoking, FE was improved (from 34 ± 19 to 76 • 40%, p .  
0.01 ). 
Conclusions: These results suggest endothelial dysfunCtion of coronary 
aden/is present even in subjects with impaired glucose tolerance, and clus- 
tenng of coronary nsk factors, smoking, and hypennsulinemna contnbute to 
the endothelial dysfunction. 
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Background: Vitamin C (VC) has been shown to improve abnormal vasomo- 
lion in the forearm circulation of diabetics and smokers. We hypothesized that 
acute VC administration would ameliorate coronary endothelial dysfunction in 
patients without obstructive coronary arte~ disease, 
Methoo~, ~:oll0wm 9 d~agnost~c ang~graphy, a 0 018 DOppler gu~0ewtfl~ 
was placed in a m~jor lett coronan/artery branch, and an ,ntusion cathete~ 
posltion(~ proxtma!ly Acetylchohne (ACh) at estimated hna! coP.centralrto~s 
of 10 ~ and 10 ~M was mtu~ tot 4 m~n each VC i2 gm ~ v ) was gwe~ 
ever 10 minutes, and ACh mfus=ons were repeated C~ne-basecl quanlrtat~ve 
coronary ang,ography (Qu,nton) was perforated at baseltP4~ and (~.Jn~ P--,.~h 
ACh infu~lon, before and after VC 
~e,~t~." lntritc0rO~ry ACh pro~ec l  v~sO~On~frtCtton in ~!~x ~ttenl~ [3 
M, 3 F), a~ 49 z 9 (mean ~ SD) years, F=ve were current smoke~,~ 3 
were hypertensive and ~ h~d elevated LDL cholesterol ( -1~0 rag/el) Peak 
ep,c~rdi~l ¢onstn~of response Io ACh b~fom VC was 19 ~ 10%, ~ 11 ~- 
9% attoP~ards (p = O.0~), VC had no eflecl on systemic hemedy~am~ Or 
ACh-*n~ ch~rtge~i maverage peak corollary fl0w velocity, coronary b~od 
flow or coret~a~ re-.~stance 
Conclu~ioo Pamnterel VC attenuat~ ep~cardlal eofona~y vaSOconstnc* 
fz0n causeO by ACh in patients wrth risk factors but w*thout o~st~cttve co~o- 
nan/artery dmease VC had no effect on the coronary resistance va~ulature 
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B~ginouf~ r Estrogen replacement therapy (ERr) ar~cl hpld-towenng dru~ 
~mpreve f low~ated  vasoddation (FMV) However, it ts unctear (t ERT plus 
hptO-toweflng therapy Ls t~tter than ellher therapy alone 
~,~-ttmcts: Twenty-three women (mean age 68 years) w~th coronary artery 
disease were enrolled ,n a random~ed, blinded 3-penod Cress-over that ol 
Premann 0.625 mg and Prevem 2.5 rng, Iovastatm 20 mcj, or both. Bract~at 
artery FMV (% ddat~on and area under dmmeter versus tfme curve (AUC)) 
were measured at baseline and after each &week treatment genoa. 
Results: EFIT plus Iovastatrn produced the greatest enhancement ~n FMV 
(% ~lat~on: 46%; AUC 69%; p < 0001 each) This improvement paralleled 
the reduction in LDL(HDL ra~o (74%; p < 0.001) associated wrth combined 
therapy 
a 
l i I r~  i I =° - r ,  LN, 
,fl B l l  roll B I [  
~1~= m~utal=n F..R,T tmtN 
Corc'fuszon ERT plus Iovastatm resuitS qn marked improvement Jn en- 
dothehu~pendent vaso~lator capacity 
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~ The Onset of LV Failure in Pressure Over load 
Hypertrophy Is More Closely Related to 
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TO establish whether LV faiture in pressure overload hypertrophy (POH) =s due 
to the deletenous effc~s of prog,~sstve chamber remodehng or tO alterahons 
fn tntnns~c myocardial tunChon, rats underwent aodtc banding or sham surgery 
(S, n = 12). At 20 wk's after surgery. LV pressure<hmens;on (P-D) mlat=ons 
were constructed from echo measurements obtained dunng load manipula- 
tions in vwo. LV chamber and myocardial function were assessed ex vnto by 
the slopes of the LV pressure-volume (LV-Ees) or lineanzed LV stress-strain 
(Myoc.-Ees) relations, respecbvety. The extent of systolic chamber enlarg- 
ment was assessed by the volume (vo) and end-systolic diameter (ESDo) 
intercepts of the pressure-volume aTrd P-C) relations, respectP.-ely Rats were 
divided into those with LV failure (increased lung wt's). POH-F (n = 19). and 
those w=thot~ f iuure. POH-NF (n = 25) 
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